In the PBMCs we could not reproduce the finding of increased IL21 expression in CD4+T-cells in SPMS patients, which is likely explained by the pooling of the groups and by the low expression level with IL21 detectable in only 53% of the PBMC samples. This evidence concerns the gene IL21 and secondary progressive multiple sclerosis.